Early changes in rpS6 phosphorylation and BH3 profiling predict response to chemotherapy in AML cellsMartin Grundy(Nottingham University Hospitals NHS Trust), Monica Pallis(Nottingham University Hospitals NHS Trust)PLoS ONEMay 3, 201810.1371/journal.pone.0196805Cited by 12SaveCiteExport RISWatch citationsRelated PapersComplementary dynamic BH3 profiles predict co-operativity between the multi-kinase inhibitor TG02 and the BH3 mimetic ABT-199 in acute myeloid leukaemia cells|Oncotarget|2016|28